or Try an Advanced Search...

    Technical Analysis for IQV - IQVIA Holdings, Inc.

    Grade Last Price % Change Price Change
    C 234.88 0.38% 0.90
    IQV closed up 0.38 percent on Friday, April 26, 2024, on 78 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 2
    *** please verify all earnings dates ***
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical IQV trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Fell Below 20 DMA Bearish 0.38%
    Gapped Down Weakness 0.38%
    Crossed Above 20 DMA Bullish -2.47%
    MACD Bullish Signal Line Cross Bullish -2.47%
    New Uptrend Bullish -2.47%
    Pocket Pivot Bullish Swing Setup -2.47%
    Up 3 Days in a Row Strength -2.47%
    Older End-of-Day Signals for IQV ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance about 16 hours ago
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    Up 1% about 21 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    IQV Chart by TradingView
    Basic chart:

    Profile

    IQVIA Holdings, Inc. Description

    IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.

    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: S&P 500 Life Sciences Technology Solutions Project Management Healthcare Service Biopharmaceutical Development Q2 Technology Enabled Healthcare Services

    Is IQV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 20 Fastest Growing Health Tech Companies in the World
    Apr 25 IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth
    Apr 24 10 Stocks Hedge Funds Are Talking About
    Apr 23 IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
    Apr 20 Should You Be Adding IQVIA Holdings (NYSE:IQV) To Your Watchlist Today?
    Apr 18 19 Best Alternatives to Discord in 2024
    Apr 17 Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now
    Apr 15 IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
    Apr 12 Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching
    Apr 8 IQVIA and Salesforce expand partnership to accelerate life sciences cloud development
    See more IQV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 261.73
    52 Week Low 167.42
    Average Volume 892,585
    200-Day Moving Average 220.31
    50-Day Moving Average 245.04
    20-Day Moving Average 236.92
    10-Day Moving Average 232.25
    Average True Range 5.71
    RSI (14) 45.36
    ADX 23.72
    +DI 21.67
    -DI 27.24
    Chandelier Exit (Long, 3 ATRs) 236.70
    Chandelier Exit (Short, 3 ATRs) 239.85
    Upper Bollinger Bands 249.61
    Lower Bollinger Band 224.22
    Percent B (%b) 0.42
    BandWidth 10.71
    MACD Line -3.00
    MACD Signal Line -3.31
    MACD Histogram 0.3166
    Fundamentals Value
    Market Cap 42.87 Billion
    Num Shares 183 Million
    EPS 5.96
    Price-to-Earnings (P/E) Ratio 39.41
    Price-to-Sales 2.68
    Price-to-Book 6.86
    PEG Ratio 1.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 240.63
    Resistance 3 (R3) 240.67 238.80 239.67
    Resistance 2 (R2) 238.80 237.34 238.78 239.35
    Resistance 1 (R1) 236.84 236.43 237.82 236.80 239.03
    Pivot Point 234.97 234.97 235.46 234.95 234.97
    Support 1 (S1) 233.01 233.51 233.99 232.97 230.73
    Support 2 (S2) 231.14 232.60 231.12 230.41
    Support 3 (S3) 229.18 231.14 230.09
    Support 4 (S4) 229.14